Clinical Trials Directory

Trials / Completed

CompletedNCT05135923

Glutenfree, Gut Microbiota and Metabolic Regulation

The Effect of Gluten-free Diet on Gut Microbiota and Metabolic Regulation in People With Coeliac Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Oslo Metropolitan University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

High intake of dietary fiber provides health benefits and reduces the risk of developing cardio-metabolic diseases, such as type 2 diabetes (T2D) and cardiovascular disease (CVD). The intake of fiber is below the recommendations worldwide. In Norway, bread and cereals represent a major source of fiber. A low fiber intake is evident for people with celiac disease due to the removal of wheat, rye and barley from the diet. We therefore need to increase our knowledge in relation to fiber-rich food that will be tolerated also by people with celiac disease. The aim of the study is to investigate the effect of fiber rich gluten free products on blood glucose levels compared to benchmark gluten free products.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRandomized, controlled trial (RCT) with parallel arms and double blindedExperiment group receive optimized gluten free products (high in fiber and whole grain) compared to comparable benchmark gluten free products (control group).

Timeline

Start date
2021-09-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-11-26
Last updated
2024-08-12

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05135923. Inclusion in this directory is not an endorsement.